Inovio Pharmaceuticals
INO
#9821
Rank
HK$0.62 B
Marketcap
HK$7.61
Share price
-4.89%
Change (1 day)
-35.82%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total debt

Total debt on the balance sheet as of March 2026 : HK$68.18 Million

According to Inovio Pharmaceuticals's latest financial reports the company's total debt is HK$68.18 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Inovio Pharmaceuticals - Total debt on balance sheet (from 1998 to 2026)

Total debt by year

Year Total debt Change
2025-12-31HK$72.88 M-20.87%
2024-12-31HK$92.11 M-60.96%
2023-12-31HK$0.23 B-5.85%
2022-12-31HK$0.25 B-2.68%
2021-12-31HK$0.25 B-14.94%
2020-12-31HK$0.30 B-60.94%
2019-12-31HK$0.77 B
2018-12-31N/A
2010-12-31N/A-100%
2009-12-31HK$93.93 M0.38%
2008-12-31HK$93.57 M
2003-12-31HK$2.56 M1494.59%
2002-12-31HK$0.16 M-57.1%
2001-12-31HK$0.37 M
2001-03-31HK$0.91 M-0.6%
2000-03-31HK$0.92 M18.88%
1999-03-31HK$0.77 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
HK$431.17 B 632,293.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$368.53 B 540,413.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$499.73 B 732,844.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$173.87 B 254,918.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$385.14 B 564,783.97%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$197.88 B 290,138.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$7.75 B 11,279.55%๐Ÿ‡บ๐Ÿ‡ธ USA